Analysis of Flora Distribution and Drug Resistance in Sputum Culture From Patients with Lung Cancer

被引:1
作者
Hao, Feng [1 ]
Ma, Ruize [1 ]
Wang, Xueyan [1 ]
Xu, Huijing [2 ]
Fang, Fang [1 ]
Zhang, Li [1 ]
Zheng, Hui [3 ]
Zang, Yuxuan [1 ]
Li, Yan [1 ]
机构
[1] Jilin Med Coll, Lab Med Coll, Changchun 132013, Jilin, Peoples R China
[2] Jilin Univ, Norman Bethune Coll Med, Changchun 130021, Jilin, Peoples R China
[3] BGI HuaDa JiYin Tianjin, Tianjin 300300, Peoples R China
来源
BIOTECHNOLOGY, CHEMICAL AND MATERIALS ENGINEERING II, PTS 1 AND 2 | 2013年 / 641-642卷
关键词
sputum culture; drug resistance; lung cancer;
D O I
10.4028/www.scientific.net/AMR.641-642.625
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
Lung cancer takes the first place among all the cancer mortality and then it becomes important to study how to use antibiotics reasonably during clinical treating. Now we analyze lung cancer patients' sputum samples Flora distribution and drug resistance and results are as follows. According to retrospective study, we analyzed lung cancer patients and identify the bacterial with routine sputum culture method strictly. At the same time, we use SPSS 19.0 soft to take a statistical analysis and judge flora drug resistance with CLSI. In the sputum culture, the rate of G- bacillus is 69.1% and it has high drug-resistance to cephalosporin, ampicillin and piperacillin, and it is sensitive to imipenem fairly. The rate of G(+) coccus is 10.1% and it is resistance to penicillin, ampicillin, oxacillin and erythromycin,and is sensitive to vancomycin. The rate of fungi is 20.8% and has obvious resistance to Pyrroles. The clinic should care more about the quality of the sputum samples, use targeted and reasonable antibiotics and control the flora drug-resistance.
引用
收藏
页码:625 / +
页数:2
相关论文
共 5 条
[1]
Update of Research on Drug Resistance in Small Cell Lung Cancer Chemotherapy [J].
Chen, Yi-Tian ;
Feng, Bing ;
Chen, Long-Bang .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) :3577-3581
[2]
Management of small cell lung cancer [J].
Ciombor K.K. ;
Lima C.M.S.R. .
Current Treatment Options in Oncology, 2006, 7 (1) :59-68
[3]
Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer [J].
Nurwidya, Fariz ;
Takahashi, Fumiyuki ;
Murakami, Akiko ;
Takahashi, Kazuhisa .
CANCER RESEARCH AND TREATMENT, 2012, 44 (03) :151-156
[4]
Do We Have Enough Evidence to Implement Particle Therapy as Standard Treatment in Lung Cancer? A Systematic Literature Review [J].
Pijls-Johannesma, Madelon ;
Grutters, Janneke P. C. ;
Verhaegen, Frank ;
Lambin, Philippe ;
De Ruysscher, Dirk .
ONCOLOGIST, 2010, 15 (01) :93-103
[5]
The potential of exploiting DNA-repair defects for optimizing lung cancer treatment [J].
Postel-Vinay, Sophie ;
Vanhecke, Elsa ;
Olaussen, Ken A. ;
Lord, Christopher J. ;
Ashworth, Alan ;
Soria, Jean-Charles .
NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (03) :144-155